Neuraxpharm
Charles Morris is an experienced executive in the field of mergers and acquisitions, currently serving as Global Head M&A and Executive Committee Member at Neuraxpharm since January 2022. Previously, Charles held the position of Global Head M&A and Corporate Development at Almirall and served as Vice President, Head of M&A for Pharma General Medicine and Animal Health at Bayer AG. Early career roles include Associate in Mergers & Acquisitions at Molecular Securities and Analyst positions in Equity Research at Merrill Lynch and Mergers & Acquisitions at Banc of America Securities LLC. Charles holds an MBA from Columbia Business School and a BA in Economics & Political Science from Emory University.
This person is not in any offices
Neuraxpharm
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders and its different therapeutic areas.